Lung Ultrasound Score and Weaning Outcome

NCT ID: NCT05289960

Last Updated: 2022-04-01

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-12-01
• Study Completion Date: 2022-03-01

Brief Summary

Objectives: Failure of extubation of patients on mechanical ventilation is one of the common problems in the ICU.

Aim of work: To evaluate the validity of lung ultrasound score in prediction of weaning outcomes and post-extubation distress.

Detailed Description

Methods: A prospective observational study of 50 patients planned for extubation who passed a spontaneous breathing trial, lung ultrasound score and serum level of NT-PRO BNP were done to all patients at end of spontaneous breathing trial, and all patients were followed after extubation and monitored for oxygenation, re-intubation rate, ICU stay, and ICU mortality.

Conditions

Lung Ultrasound Score; Acute Respiratory Failure

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

patients eligible for weaning by spontaneous breathing trial

Group Type: OTHER

lung ultrasound

Intervention Type: OTHER

Lung ultrasound score was done at the end of SBT using curved array ultrasound probe 2-5 MHz, Siemens X300, Korea

non invasive ventilation after weaning

Group Type: OTHER

lung ultrasound

Intervention Type: OTHER

Lung ultrasound score was done at the end of SBT using curved array ultrasound probe 2-5 MHz, Siemens X300, Korea

Interventions

lung ultrasound

Lung ultrasound score was done at the end of SBT using curved array ultrasound probe 2-5 MHz, Siemens X300, Korea

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• 1. Patients age > 18 years

2. Patients intubated and mechanically ventilated for more than 48 hours in the intensive care unit and planned for extubation.

Exclusion Criteria

• 1. Patients < or =18 years 2. Patients with left ventricular failure

3. Right ventricular failure

4. Pulmonary hypertension

5. Aortic valve disease

6. Hyperthyroidism

7. Tracheostomy

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Cairo University

OTHER

Sponsor Role: lead

Responsible Party

Mostafa Farouk

lecturer

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

farouk faris, MD

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Cairo University Hospitals

Cairo, , Egypt

Countries

Egypt

Other Identifiers

MS-490-2020

Identifier Type: -

Identifier Source: org_study_id